Adjuvant Chemotherapy for Node-positive Esophageal Squamous Cell Carcinoma Improves Survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant Chemotherapy for Node-positive Esophageal Squamous Cell Carcinoma Improves Survival

Published:2021-10 Issue: Volume: Page:
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Feng Shao-Kang,Liu Xian-Ben,Xing Wen-Qun,Liu Yang,Chen Pei-Nan,Jiang Duo,Sun Hai-Bo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Cancer incidence and mortality: a cohort study in China, 2008-2013;Pan;Int J Cancer,2017

4. Cancer incidence and mortality in China, 2013;Chen;Cancer Lett,2017

5. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma;Zhang;Dis Esophagus,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy;Journal of Cancer Research and Clinical Oncology;2024-08-07

2. Optimal extent of lymphadenectomy improves prognosis and guides adjuvant chemotherapy in esophageal cancer: A propensity score-matched analysis;World Journal of Gastrointestinal Surgery;2024-06-27

3. Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: a retrospective cohort study;2024-05-23

4. Neoadjuvant Chemotherapy or Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2023-11-14

5. A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinoma;Future Oncology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3